The potential of extracellular protein antigens of Staphylococcus aureus as markers of infection of bone was investigated by immunoblotting. Serum from patients with S. aureus bone infection showed levels of IgG antibodies to a preparation of soluble extracellular proteins of 17–81 kDa which were significantly higher than those found in serum from normal controls. By contrast, immunoblots of various whole cell or cell wall-derived antigens gave complex patterns of response which were unsuitable for positive diagnosis of S. aureus bone infection.
WergelandH. I.,
HaaheimL. R.,
NatasO. B.,
WesenbergF.,
OedingP. Antibodies to staphylococcal peptidoglycan and its peptide epitopes, teichoic acid, and lipoteichoic acid in sera from blood donors and patients with staphylococcal infections. J Clin Microbiol1989; 27:1286–1291
ThomasV. L.,
SanfordB. A.,
KeoghB. S.,
TriplettR. G. Antibody response to Staphylococcus aureus surface proteins in rabbits with persistent osteomyelitis after treatment with demineralized bone implants. Infect Immun1989; 57:404–412
PowerM. E.,
OlsonM. E.,
DomingueP. A. G.,
CostertonJ. W. A rat model of Staphylococcus aureus chronic osteomyelitis that provides a suitable system for studying human infection. J Med Microbiol1990; 33:189–198
ArvidsonS. O. Extracellular enzymes from Staphylococcusaureus
. In
EasmonC. S. F.,
AdlamC.
(eds) Staphylococci and staphylococcal infections London: Academic Press; 1983; 2745–808
KriklerS. J.,
PenningtonT. H.,
PetrieD. Typing of strains of Staphylococcus aureus by Western blot analysis of culture supemates. J Med Microbiol1986; 21:169–171
LugtenbergB.,
MeijersJ.,
PetersR.,
Van Der HoekP.,
Van AlphenL. Electrophoretic resolution of the ‘major outer membrane protein’ of Escherichia coli K12 into four bands. FEBS Lett1975; 58:254–258
EspersenF.,
SchiotzP. O. Normally–occurring precipitating antibody against Staphylococcus aureus in human serum and colostrum. Acta Pathol Microbiol Scand Sect C1981; 89:93–98
BellJ. A.,
PenningtonT. H.,
PetrieD. T. Western blot analysis of staphylococcal antibodies present in human sera during health and disease. J Med Microbiol1987; 23:95–99
JeljaszewiczJ.,
SwitalskiL. M.,
AdlamC. Staphylocoagulase and clumping factor. In
EasmonC. S. F.,
AdlamC.
(eds) Staphylococci and staphylococcal infections London: Academic Press; 1983; 2525–527
ArbuthnottJ. P. Epidermolytic toxins. In
EasmonC. S. F.,
AdlamC.
(eds) Staphylococci and staphylococcal infections London: Academic Press; 1983; 2599–617
SchlievertP. M.,
SchoettleD. J.,
WatsonD. W. Purification and physicochemical and biological characterisation of a staphylococcal pyrogenic exotoxin. Infect Immun1979; 23:609–617
SchlievertP. M.,
ShandsK. N.,
DanB. B.,
SchmidG. P.,
NishimuraR. D. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J Infect Dis1981; 143:509–516
BergdollM. S.,
CrassB. A.,
ReiserR. F.,
RobbinsR. N.,
DavisJ. P. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic–shock–syndrome Staphylococcus aureus isolates. Lancet1981; 1:1017–1021
MollbyR. Isolation and properties of membrane damaging toxins. In
EasmonC. S. F.,
AdlamC.
(eds) Staphylococci and staphylococcal infections London: Academic Press; 1983; 2619–669
Mayberry-CarsonK. J.,
Tober-MeyerB.,
SmithJ. K.,
LambeD. W.,
CostertonJ. W. Bacterial adherence and glycocalyx formation in osteomyelitis experimentally induced with Staphylococcus aureus
. Infect Immun1984; 43:825–833
HØibyN.,
FlensborgE. W.,
BeckB.,
FriisB.,
JacobsenS. V.,
JacobsenL.Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins by means of crossed immune-electrophoresis. Scand J Respir Dis1977; 58:65–79